HW&C
HC Wainwright & Co. Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
751
C4 Therapeutics
CCCC
$188M
|
AF
Andrew Fein
| $2.64 | $7 |
165%
upside
| Buy |
2 Nov ‘23
1 year ago |
|
752
Traws Pharma
TRAW
$12.9M
|
JP
Joseph Pantginis
| $1.83 | $11 |
501%
upside
| Buy |
12 Oct ‘23
1 year ago |
|
753
Atara Biotherapeutics
ATRA
$82.7M
| $11.78 | $700 |
5,842%
upside
| Buy |
26 Sep ‘23
1 year ago |
|
|
754
Ensysce Biosciences
ENSC
$6.35M
|
RS
Raghuram Selvaraju
| $2.14 | $105 |
4,807%
upside
| Buy |
25 Sep ‘23
1 year ago |
|
755
Anebulo Pharmaceuticals
ANEB
$84.6M
|
RS
Raghuram Selvaraju
| $2.06 | $6 |
191%
upside
| Buy |
25 Sep ‘23
1 year ago |
|
|
OKUR
756
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$33.8M
|
GS
Gobind Singh
| $2.50 | $300 |
11,900%
upside
| Buy |
8 Sep ‘23
2 years ago |
|
|
ADTX
757
Aditxt
ADTX
$4.89M
|
MK
Mitchell Kapoor
| $0.9820 | $610,000 |
62,118,026%
upside
| Buy |
6 Sep ‘23
2 years ago |
|
758
Fabrinet
FN
$13.3B
|
MC
Matthew Caufield
| $372.57 | $28 |
92%
downside
| Buy |
22 Aug ‘23
2 years ago |
|
759
Cartesian Therapeutics
RNAC
$255M
|
RS
Raghuram Selvaraju
| $9.81 | $5 |
49%
downside
| Buy |
18 Aug ‘23
2 years ago |
|
760
Pulmatrix
PULM
$18.3M
|
AF
Andrew Fein
| $5 | $10 |
100%
upside
| Buy |
15 Aug ‘23
2 years ago |
|
761
Quest Resource Holding
QRHC
$35.8M
|
AD
Amit Dayal
| $1.73 | $12 |
594%
upside
| Buy |
15 Aug ‘23
2 years ago |
|
762
GT Biopharma
GTBP
$2.85M
|
RB
Robert Burns
| $0.8000 | $150 |
18,650%
upside
| Buy |
8 Aug ‘23
2 years ago |
|
|
ABTC
763
American Bitcoin Corp. Class A Common Stock
ABTC
$734M
|
SB
Scott Buck
| $8.87 | $16 |
80%
upside
| Neutral |
2 Jun ‘23
2 years ago |
|
764
AYTU BioPharma
AYTU
$20.5M
|
VB
Vernon Bernardino
| $2.28 | $20 |
777%
upside
| Buy |
31 May ‘23
2 years ago |
|
765
Q32 Bio
QTTB
$21.7M
|
PT
Patrick Trucchio
| $1.78 | $360 |
20,125%
upside
| Buy |
15 May ‘23
2 years ago |
|
766
Onconetix
ONCO
$4.25M
|
VB
Vernon Bernardino
| $2.75 | $9 |
227%
upside
| Buy |
26 Apr ‘23
2 years ago |
|
767
POET Technologies
POET
$508M
|
KD
Kevin Dede
| $5.60 | $5 |
11%
downside
| Buy |
26 Apr ‘23
2 years ago |
|
768
ENDRA Life Sciences
NDRA
$3.2M
|
VB
Vernon Bernardino
| $4.25 | $15,750 |
370,488%
upside
| Buy |
31 Mar ‘23
2 years ago |
|
|
IMA
769
ImageneBio, Inc. Common Stock
IMA
$99.6M
|
RB
Robert Burns
| $8.91 | $264 |
2,863%
upside
| Buy |
17 Mar ‘23
2 years ago |
|
|
DVLT
770
Datavault AI Inc. Common Stock
DVLT
$31.4M
|
KD
Kevin Dede
| $0.3212 | $750 |
233,399%
upside
| Buy |
17 Mar ‘23
2 years ago |
|
771
Lineage Cell Therapeutics
LCTX
$276M
| $1.21 | $7 |
479%
upside
| Buy |
10 Mar ‘23
2 years ago |
|
|
|
CLYM
772
Climb Bio, Inc. Common Stock
CLYM
$161M
|
DT
Douglas Tsao
| $2.38 | $6 |
152%
upside
| Neutral |
8 Mar ‘23
2 years ago |
|
773
Seres Therapeutics
MCRB
$154M
|
VB
Vernon Bernardino
| $17.59 | $500 |
2,743%
upside
| Buy |
8 Mar ‘23
2 years ago |
|
774
vTv Therapeutics
VTVT
$49.8M
|
VB
Vernon Bernardino
| $19.02 | $240 |
1,162%
upside
| Buy |
7 Mar ‘23
2 years ago |
|
775
Spyre Therapeutics
SYRE
$977M
|
EW
Edward White
| $16.18 | $25 |
55%
upside
| Neutral |
3 Mar ‘23
2 years ago |
|